☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Extensive-Stage SCLC
Bristol-Myers' Opdivo and Yervoy Combination Couldn't Meet OS as Maintenance Therapy in esSCLC Patients Post 1L Chemo
November 27, 2018
Load more...
Back to Home